GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM39439
Query DataSets for GSM39439
Status
Public on Apr 01, 2005
Title
pp186-4
Sample type
RNA
Source name
Staged C. elegans embryos
Organism
Caenorhabditis elegans
Extracted molecule
total RNA
Description
Mutant genotype pie-1(zu154); pal-1(RNAi) 186 minutes after the 4-cell embryonic stage at 22 degrees C
Sample_genotype: pp
Sample_time: 186
Submission date
Jan 24, 2005
Last update date
May 27, 2005
Contact name
Andrew Hill
E-mail(s)
andrew.hill@pfizer.com
Phone
617-674-6341
Organization name
Pfizer
Department
Research Business Technology
Street address
300 Technology Square
City
Cambridge
State/province
MA
ZIP/Postal code
02139
Country
USA
Platform ID
GPL200
Series (1)
GSE2180
C. elegans embryonic timecourse in wt and mutant embryos
Data table header descriptions
ID_REF
Affymetrix Qualifier
VALUE
RMA calulated using Bioconductor Affy package (http://www.bioconductor.org)
Data table
ID_REF
VALUE
171720_x_at
3.78680781913535
171721_x_at
4.79435954407815
171722_x_at
6.39822288388259
171723_x_at
3.29219224537347
171724_x_at
4.24581663924327
171725_x_at
4.44038531358657
171726_x_at
4.69678853104364
171727_x_at
2.9035813510938
171728_x_at
3.39199344018455
171729_x_at
6.78226975425841
171730_x_at
2.72392455844827
171731_x_at
8.50881730654238
171732_x_at
6.57102500203207
171733_x_at
8.22191377406054
171734_x_at
9.33646907916676
171735_x_at
2.99320425703419
171736_x_at
9.18094855023979
171737_x_at
8.67209953753122
171738_x_at
7.14020693967112
171739_x_at
2.80756689286688
Total number of rows:
22625
Table truncated, full table size
608 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM39439.CEL.gz
2.6 Mb
(ftp)
(http)
CEL
GSM39439.EXP.gz
327 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
